Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (511-520 of 527) with videos related to

Pageof 53
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2021
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, et al.
Infectious Diseases and Therapy|December 30, 2021
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, et al.
Journal of Hepatology|June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the worldSahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Viruses|February 26, 2022
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsYen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, et al.
Digestive Diseases and Sciences|July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in TaiwanChin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Hepatology International|February 4, 2026
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across AsiaYasuto Takeuchi, Ryosuke Tateishi, Shuntaro Obi, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 53

Showing results (511-520 of 527) with videos related to

Sort By:
Pageof 53
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2021
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)Chung-Feng Huang, Kuo-Chih Tseng, Pin-Nan Cheng, et al.
Infectious Diseases and Therapy|December 30, 2021
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in TaiwanPin-Nan Cheng, Lein-Ray Mo, Chun-Ting Chen, et al.
Journal of Hepatology|June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the worldSahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Viruses|February 26, 2022
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting AntiviralsYen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, et al.
Digestive Diseases and Sciences|July 4, 2024
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in TaiwanChin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Hepatology International|February 4, 2026
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across AsiaYasuto Takeuchi, Ryosuke Tateishi, Shuntaro Obi, et al.
The American Journal of Gastroenterology|June 14, 2026
Higher incidence of hepatocellular carcinoma in suppressed hepatitis B cirrhosis compared to cured hepatitis C cirrhosisJiyoon Park, Sally Tran, Eiichi Ogawa, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 53